Sakai, Japan

Hiroyuki Kimura

This inventor holds 22 USPTO granted patents, primarily in Heterocyclic Compounds. Top assignees: Takeda Pharmaceutical Company Limited, Takeda Chemical Industries, Inc., Shiseido Company, Limited. Active years: 1992-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroyuki Kimura. Retrieved from https://idiyas.com/inventor/hiroyuki-kimura-x4kittm5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 40.9

Average Co-Inventor Count = 4.4

ph-index = 9

Forward Citations = 183(Granted Patents)


Location History:

  • Sakai, JP (1992 - 2009)
  • Osaka, JP (2005 - 2016)

Company Filing History:


Years Active: 1992-2016

Loading Chart...
Areas of Expertise:
Calcium Receptor Modulators
JNK Inhibitors
Heterocyclic Compounds
Thiazole Compounds
Hypoglycemic Activity
Retinoid Receptors
Alkanoic Acid Derivatives
GABA Transporter Protein
Adenosine A3 Receptor Antagonists
Oxyiminoalkanoic Acid
Microorganism Resistance
Glyceraldehyde-3-Phosphate Dehydrogenase
22 patents (USPTO):Explore Patents

Title: Hiroyuki Kimura: Innovator in Calcium Receptor Modulating Agents

Introduction: Hiroyuki Kimura is a distinguished inventor based in Sakai, Japan, with an impressive portfolio of 22 patents. His innovative contributions, particularly in the field of calcium receptor modulation, have garnered significant attention in the scientific community.

Latest Patents: Among his most recent patents is a groundbreaking invention involving substituted pyrazolo[1,5-A]pyrimidines as calcium receptor modulating agents. The patent presents a calcium receptor modulator that comprises a compound represented by a complex formula. In this context, ring A is defined as an optionally substituted 5- to 7-membered ring, while ring B represents an optionally substituted 5- to 7-membered heterocyclic ring. Specific variables within the formula, such as X, R, Y, and Z, are meticulously defined, allowing for a comprehensive understanding of the compound's structure and potential applications. These innovations aim to enhance the modulation of calcium receptors, which can have implications for various therapeutic applications.

Career Highlights: Hiroyuki Kimura's career includes significant roles at notable companies, including Takeda Pharmaceutical Company Limited and Takeda Chemical Industries, Inc. These positions have allowed him to contribute to the advancement of pharmaceuticals, particularly in receptor modulation mechanisms.

Collaborations: Throughout his career, Kimura has collaborated with esteemed colleagues such as Hiroyuki Odaka and Yu Momose. These partnerships have further enriched his work and innovations in the pharmaceutical sector.

Conclusion: With a substantial number of patents to his name and a focus on calcium receptor modulation, Hiroyuki Kimura has established himself as a pivotal figure in the realm of pharmaceutical innovations. His contributions continue to influence research and development, demonstrating the impact of inventive minds in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…